Dr Marlen Lauffer

Dr Marlen Lauffer is head of the Interventional Precision Genomics Lab at the University of Oxford, where she develops international consensus frameworks and computational pipelines for the systematic identification of therapeutic opportunities across multiple genetic therapeutic modalities for rare genetic diseases. Dr Lauffer plays a central role in several national and international initiatives advancing the development of genetic therapies, including the global N=1 Collaborative. She will co-lead our Therapeutic Innovation and Trials community to help accelerate the development and clinical translation of innovative and personalised treatments.